1.Isolation and cloning of an aryl-aldehyde dehydrogenase gene from the white-rot fungus Pycnoporus cinnabarinus strain MUCL 39533
Khai Lun Ong ; Siew Ling Liew ; Sahilah Abdul Mutalib ; Abdul Munir Abdul Murad ; Farah Diba Abu Bakar
Malaysian Journal of Microbiology 2015;11(4):391-397
Aims: The white rot fungus Pycnoporus cinnabarinus MUCL 39533 is able to reduce vanillic acid to vanillin. Reduction of
vanillic acid to vanillin catalysed by the key enzyme aryl-aldehyde dehydrogenase has been reported. Here we report the
isolation and cloning of aryl-aldehyde dehydrogenase from P. cinnabarinus strain MUCL 39533.
Methodology and results: An aryl-aldehyde dehydrogenase gene (PcALDH) was isolated from P. cinnabarinus by
producing a partial cDNA sequence fragment of an aryl-aldehyde dehydrogenase gene through PCR. Degenerate PCR
primers were designed based on codons corresponding to conserved amino acid regions of aryl-aldehyde
dehydrogenases of several fungi and bacteria. The full-length PcALDH cDNA was obtained through ReverseTranscription-Polymerase
Chain Reaction (RT-PCR) and Rapid Amplification cDNA Ends (RACE) PCR. PcALDH cDNA
comprises an open reading frame of 1,506 bp that encodes a protein of 501 amino acids. The PcALDH predicted protein
showed the highest amino acid sequence identity (84%) to ALDH from Trametes versicolor. In silico analysis of PcALDH
indicated that it belongs to the ALDH super-family and Class 3 ALDH.
Conclusion, significance and impact study: PcALDH cDNA was successfully isolated and characterized. Important
motifs identified from the highly conserved PcALDH protein indicated that it belongs to the aldehyde dehydrogenase superfamily.
The cDNA clone will be used in expression studies to confirm the catalytic function of the enzyme.
Vanillic Acid
;
Flavoring Agents
2.Assessing Airflow Limitation among Smokers in a Primary Care Setting
Chean Kooi YAU ; Irfhan Ali Hyder Ali ; Fairuz Fadzilah RAHIM ; Chin Jiunn SHENG ; Choi Xin LING ; Liew Kah WENG ; Tan Chia CHIA ; Tan Kean CHYE ; Ooi Siew TING ; Tan Hong JIN
Malaysian Journal of Medical Sciences 2018;25(3):78-87
Background: Many smokers have undiagnosed chronic obstructive pulmonary disease(COPD), and yet screening for COPD is not recommended. Smokers who know that they haveairflow limitation are more likely to quit smoking. This study aims to identify the prevalence andpredictors of airflow limitation among smokers in primary care.Methods: Current smokers ≥ 40 years old who were asymptomatic clinic attendees in aprimary care setting were recruited consecutively for two months. We used a two-step strategy.Step 1: participants filled in a questionnaire. Step 2: Assessment of airflow limitation using apocket spirometer. Multiple logistic regression was utilised to determine the best risk predictorsfor airflow limitation.Results: Three hundred participants were recruited. Mean age was 58.35 (SD 10.30) yearsold and mean smoking history was 34.56 pack-years (SD 25.23). One in two smokers were found tohave airflow limitation; the predictors were Indian ethnicity, prolonged smoking pack-year historyand Lung Function Questionnaire score ≤ 18. Readiness to quit smoking and the awareness ofCOPD were low.Conclusions: The high prevalence of airflow limitation and low readiness to quit smokingimply urgency with helping smokers to quit smoking. Identifying airflow limitation as an additionalmotivator for smoking cessation intervention may be considered. A two-step case-finding methodis potentially feasible.
3.Orally Disintegrating Film: A Review of Its Formulation and Manufacturing Method
Kai Bin Liew ; Ganesan Gobal ; Hanifah Mohd Rofiq ; Hiu Ching Phang ; Siew-Keah Lee ; Long Chiau Ming ; A.B.M. Helal Uddin ; Yik Ling Chew ; Vijayakumar Lakshminarayanan
Malaysian Journal of Medicine and Health Sciences 2023;19(No.6):297-303
Oral route drug delivery system is still considered as the most convenient and patient friendly drug delivery route.
Over the decades, many research has been performed to improve the functionality oral dosage form. Orally disintegrating film (ODF) is a newer oral drug delivery system, which is in the form of a thin film that will disintegrate in
the oral cavity within a matter of seconds. The aim of this review paper is to recap ODF, its benefits, formulation
contents and manufacturing method. With more research and development work has been conducted on ODF, the
dosage form is expected to be manufactured and scaled up to be commercializable products to be sold in the market.